Niosomes and discomes for ocular delivery of naltrexone hydrochloride: Morphological, rheological, spreading properties and photo-protective effects

International Journal of Pharmaceutics

Volumn 433, Issue 1-2, 2012, Pages 142-148

  Abdelkader, Hamdy ^a,b   Wu, Zimei ^a   Al Kassas, Raida ^a   Alany, Raid G ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Minia University   (Egypt)

^c KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Autoxidation; Contact angle; Discomes; Naltrexone hydrochloride; Niosomes; Viscosity

Indexed keywords

DISCOME; DRUG CARRIER; LIPID; NALTREXONE; NIOSOME; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; AUTOOXIDATION; CHEMICAL COMPOSITION; CONTACT ANGLE; CONTROLLED STUDY; DISPERSION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; FLOW KINETICS; ILLUMINATION; MORPHOLOGY; PRIORITY JOURNAL; SUNLIGHT PROTECTION; SURFACE TENSION; VISCOSITY;

ADMINISTRATION, OPHTHALMIC; CORNEAL DISEASES; DIABETES COMPLICATIONS; DRUG STABILITY; LIGHT; LIPIDS; LIPOSOMES; NALTREXONE; NARCOTIC ANTAGONISTS; OXIDATION-REDUCTION; PARTICLE SIZE; PHOTOLYSIS; RHEOLOGY; VISCOSITY;

EID: 84862839840     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.05.011     Document Type: Article

References (26)

1. Abdelkader, H., Ismail, S., Kamal, H., Alany, R.G., 2011a. Design and evaluation of controlled release niosomes and discomes for naltrexone hydrochloride ocular delivery. J. Pharm. Sci. 100, 1833-1846.
2. Abdelkader, H., Wu, Z., Al-Kassas, R., Brown, J.E., Alany, R., 2011b. Preformulation characteristics of the opioid growth factor antagonist-naltrexone hydrochloride: stability and lipophilicity studies. J. Drug Deliv. Sci. Technol. 21, 157-163.
3. Abdelkader, H., Patel, D., McGhee, C., Alany, R.G., 2011c. New therapeutic approaches in treatment of diabetic keratopathy. Clinic. Experimental Opthalmol. 39, 259-270.
4. Arunothayanun, P., Florence, A.T., 2000. Rheology of niosomes dispersions. In: Uchegbu, I.F. (Ed.), Synthetic Surfactant Vesicles: Niosomes and Other Nonphospholipid Vesicular Systems. Harwood Academic Publishers, Singapore, pp. 25-48.
5. Burgalassi, S., Chetoni, P., Panichi, L., Boldrini, E., Saettone, M.F., 2000. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits. J. Ocul. Pharmacol. Ther. 16, 497-509.
6. Chrai, S.S., Robinson, J.R., 1974. Ocular evaluation of methylcellulose vehicle in albino rabbits. J. Pharm. Sci. 63, 1218-1223.
7. Florence, A.T., Attwood, D., 1998a. Drug stability. In: Florence, A.T., Attwood, D. (Eds.), Physicochemical Principles of Pharmacy., 3rd ed. Macmillan Press Ltd., London, pp. 101-151.
8. Florence, A.T., Attwood, D., 1998b. Properties of the solid state. In: Florence, A.T., Attwood, D. (Eds.), Physichochemical Principles of Pharmacy. McMillan Press Ltd., London, pp. 5-35.
9. Kirby, C.J., Gregoriadis, G., 1984. A simple procedure for preparing liposomes capable of high encapsulation efficiency under mild conditions. In: Gregoriadis, G. (Ed.), Liposome Technology, vol. 1. CRC Press, Florida, pp. 19-27.
10. Lang, J.C., Roehrs, R.E., Rodeheaver, D.P., Missel, P.J., Jani, R., Chowhan, M.A., 2002. Design and evaluation of ophthalmic pharmaceutical products. In: Banker, G.S., Rhodes, C.T. (Eds.), Modern Pharmaceutics. Marcel Dekker, NY, USA, pp. 626-717.
11. Lerk, C.F., Lagas, M., Boelstra, J.P., Broersma, P., 1977. Contact angles of pharmaceutical powders. J. Pharm. Sci. 66, 1480-1481.
12. Ludwig, A., 2005. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv. Rev. 57, 1595-1639. (Pubitemid 41443472)
13. Manconi, M., Valenti, D., Sinico, C., Lai, F., Loy, G., Fadda, A.M., 2003. Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int. J. Pharm. 260, 261-272. (Pubitemid 36773923)
14. Martin, A., Bustamante, P., Chun, A.H.C., 1993. Rheology. In: Martin, A. (Ed.), Physical Pharmacy., 4th ed. Lippincott Williams & Wilkins, Baltimore, Maryland, pp. 453-476.
15. McLaughlin, P.J., Sassani, J.W., Klocek, M.S., Zagon, I.S., 2010. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review. Brain Res. Bull. 81, 236-247.
16. Pawar, P.K., Majumdar, D.K., 2006. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep and buffalo corneas. AAPS PharmSciTech 7, E1-E6.
17. Rathore, M.S., Majumdar, D.K., 2006. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS Pharm- SciTech 12, E12-E17.
18. Roda, A., Russo, C., Pasini, P., Piazza, F., Feroci, G., Kricka, L.J., et al., 1998. Antioxidant properties of bile salt micelles evaluated with different chemiluminescent assays: a possible physiological role. J. Biolumin. Chemilumin. 13, 327-337.
19. Uchegbu, I.F., Bouwstra, J.A., Florence, A.T., 1992. Large disk-shaped structures (Discomes) in non-ionic surfactant vesicles to micelle transitions. J. Phys. Chem. 96, 10548-10553.
20. Uchegbu, I.F., Florence, A.T., 1995. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv. Colloid Interface Sci. 58, 1-55.
21. Uchegbu, I.F., McCarthy, D., Schätzlein, A., Florence, A.T., 1996. Phase-transitions in aqueous dispersions of the hexadecyl diglycerol ether (C16G2) non-ionic surfactant, cholesterol and cholesteryl poly-24-oxyethylene ether-vesicles, tubules, discomes and micelles. STP Pharm. Sci. 6, 33-43.
22. Uchegbu, I.F., Vyas, S.P., 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. 172, 33-70. (Pubitemid 28430243)
23. Vyas, S.P., Mysore, N., Jaittley, V., Venkatesan, N., 1998. Discoidal niosome based controlled ocular delivery of Timolol maleate. Pharmazie 53, 466-469. (Pubitemid 28338283)
24. Winfield, A.J., Jessiman, D., Williams, A., Esakowitz, L., 1990. A study of the causes of non-compliance by patients prescribed eyedrops. Br. J. Ophthalmol. 74, 477-480. (Pubitemid 20269092)
25. Zagon, I.S., Klocek, M.S., Sassani, J.W., McLaughlin, P.J., 2009. Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus. Arch. Ophthalmol. 127, 1468-1473.
26. Zagon, I.S., Sassani, J.W., Myers, R.L., McLaughlin, P.J., 2007. Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium. Brain Res. Bull. 72, 18-24. (Pubitemid 46227741)